Identification of a Novel de Novo p.Phe932Ile KCNT1 Mutation in a Patient With Leukoencephalopathy and Severe Epilepsy

Abstract Background More than half of patients with genetic leukoencephalopathies remain without a specific diagnosis; this is particularly true in individuals with a likely primary neuronal etiology, such as those in which abnormal white matter occurs in combination with severe epilepsy. Patient A...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric neurology 2014, Vol.50 (1), p.112-114
Hauptverfasser: Vanderver, Adeline, MD, Simons, Cas, PhD, Schmidt, Johanna L., MPH, MGC, Pearl, Philip L., MD, Bloom, Miriam, MD, Lavenstein, Bennett, MD, Miller, David, Grimmond, Sean M., PhD, Taft, Ryan J., PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Background More than half of patients with genetic leukoencephalopathies remain without a specific diagnosis; this is particularly true in individuals with a likely primary neuronal etiology, such as those in which abnormal white matter occurs in combination with severe epilepsy. Patient A child with a severe early infantile epileptic encephalopathy and abnormal myelination underwent whole exome sequencing. Results Whole exome sequencing identified a heterozygous de novo mutation in KCNT1, a sodium-gated potassium channel gene. Conclusions Severely delayed myelination was anecdotally reported in previous patients with KCNT1 mutations. This case reinforces that KCNT1 sequencing should be included in an investigation of patients with severely delayed myelination and epilepsy.
ISSN:0887-8994
1873-5150
DOI:10.1016/j.pediatrneurol.2013.06.024